Mesenchymal stem cells (MSCs) are derived from a wide range of sources and easily
isolated and cultured. MSCs have the capacity for in vitro amplification and self-renewal, low …

Cardiovascular disease (CVD) accounts for more deaths globally than any other single
disease. There are on average 1.5 million episodes of myocardial infarction (heart attack) …

Ischemic heart damage usually triggers cardiomyopathological remodeling and fibrosis, thus
promoting the development of heart functional failure. Mesenchymal stem cells (MSCs) are a …

Heart failure is one of the most important cardiovascular health problems throughout the
world and has high mortality, and there is a need to develop more effective therapeutic …

Importance of the field: Mesenchymal stem cells (MSCs) have the greatest potential for use
in cell-based therapy of human heart diseases, especially in myocardial infarcts. The …

Experimental and early clinical data suggest that, due to several unique properties,
mesenchymal stem cells (MSCs) may be more effective than other cell types for diseases …

Mesenchymal stem cells (MSCs) are a prototypical adult stem cell with capacity for self-
renewal and differentiation with a broad tissue distribution. Initially described in bone …

Mesenchymal stem cell (MSC) is an intensely studied stem cell type applied for cardiac
repair. For decades, the preclinical researches on animal model and clinical trials have …

Administration of mesenchymal stem cells (MSCs) to diseased hearts improves cardiac
function and reduces scar. These effects occur via stimulation of endogenous repair …

Current treatments for ischemic cardiomyopathy are aimed toward minimizing the
deleterious consequences of diseased myocardium. The possibility of treating heart failure …